Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis

NCT05397938 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

231

Enrollment

INDUSTRY

Sponsor class

Conditions

Glucocorticoid Induced Osteoporosis

Interventions

DRUG: JMT103
DRUG: Alendronate sodium
DRUG: JMT103 placebo
DRUG: Alendronate sodium placebo

Sponsor

Shanghai JMT-Bio Inc.